Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Reduced activity and connectivity of left amygdala in patients with schizophrenia treated with clozapine or olanzapine.

Mier D, Schirmbeck F, Stoessel G, Esslinger C, Rausch F, Englisch S, Eisenacher S, de Haan L, Meyer-Lindenberg A, Kirsch P, Zink M.

Eur Arch Psychiatry Clin Neurosci. 2018 Dec 11. doi: 10.1007/s00406-018-0965-4. [Epub ahead of print]

PMID:
30539230
2.

Area-specific information processing in prefrontal cortex during a probabilistic inference task: a multivariate fMRI BOLD time series analysis.

Demanuele C, Kirsch P, Esslinger C, Zink M, Meyer-Lindenberg A, Durstewitz D.

PLoS One. 2015 Aug 10;10(8):e0135424. doi: 10.1371/journal.pone.0135424. eCollection 2015.

3.

Corticothalamic phase synchrony and cross-frequency coupling predict human memory formation.

Sweeney-Reed CM, Zaehle T, Voges J, Schmitt FC, Buentjen L, Kopitzki K, Esslinger C, Hinrichs H, Heinze HJ, Knight RT, Richardson-Klavehn A.

Elife. 2014 Dec 23;3:e05352. doi: 10.7554/eLife.05352.

4.

Metamemory in schizophrenia: retrospective confidence ratings interact with neurocognitive deficits.

Eifler S, Rausch F, Schirmbeck F, Veckenstedt R, Mier D, Esslinger C, Englisch S, Meyer-Lindenberg A, Kirsch P, Zink M.

Psychiatry Res. 2015 Feb 28;225(3):596-603. doi: 10.1016/j.psychres.2014.11.040. Epub 2014 Dec 2.

PMID:
25530415
5.

Amygdala habituation: a reliable fMRI phenotype.

Plichta MM, Grimm O, Morgen K, Mier D, Sauer C, Haddad L, Tost H, Esslinger C, Kirsch P, Schwarz AJ, Meyer-Lindenberg A.

Neuroimage. 2014 Dec;103:383-390. doi: 10.1016/j.neuroimage.2014.09.059. Epub 2014 Oct 2.

6.

Increased orbitofrontal cortex activation associated with "pro-obsessive" antipsychotic treatment in patients with schizophrenia.

Schirmbeck F, Mier D, Esslinger C, Rausch F, Englisch S, Eifler S, Meyer-Lindenberg A, Kirsch P, Zink M.

J Psychiatry Neurosci. 2015 Mar;40(2):89-99.

7.

Reduced activation in ventral striatum and ventral tegmental area during probabilistic decision-making in schizophrenia.

Rausch F, Mier D, Eifler S, Esslinger C, Schilling C, Schirmbeck F, Englisch S, Meyer-Lindenberg A, Kirsch P, Zink M.

Schizophr Res. 2014 Jul;156(2-3):143-9. doi: 10.1016/j.schres.2014.04.020. Epub 2014 May 13.

PMID:
24831391
8.

Further evidence for the impact of a genome-wide-supported psychosis risk variant in ZNF804A on the Theory of Mind Network.

Mohnke S, Erk S, Schnell K, Schütz C, Romanczuk-Seiferth N, Grimm O, Haddad L, Pöhland L, Garbusow M, Schmitgen MM, Kirsch P, Esslinger C, Rietschel M, Witt SH, Nöthen MM, Cichon S, Mattheisen M, Mühleisen T, Jensen J, Schott BH, Maier W, Heinz A, Meyer-Lindenberg A, Walter H.

Neuropsychopharmacology. 2014 Apr;39(5):1196-205. doi: 10.1038/npp.2013.321. Epub 2013 Nov 19.

9.

Test-retest reliability of fMRI-based graph theoretical properties during working memory, emotion processing, and resting state.

Cao H, Plichta MM, Schäfer A, Haddad L, Grimm O, Schneider M, Esslinger C, Kirsch P, Meyer-Lindenberg A, Tost H.

Neuroimage. 2014 Jan 1;84:888-900. doi: 10.1016/j.neuroimage.2013.09.013. Epub 2013 Sep 18.

PMID:
24055506
10.

The Early Recognition Inventory ERIraos detects at risk mental states of psychosis with high sensitivity.

Rausch F, Eifler S, Esser A, Esslinger C, Schirmbeck F, Meyer-Lindenberg A, Zink M.

Compr Psychiatry. 2013 Oct;54(7):1068-76. doi: 10.1016/j.comppsych.2013.04.016. Epub 2013 Jun 4.

PMID:
23759152
11.

Application of high-frequency repetitive transcranial magnetic stimulation to the DLPFC alters human prefrontal-hippocampal functional interaction.

Bilek E, Schäfer A, Ochs E, Esslinger C, Zangl M, Plichta MM, Braun U, Kirsch P, Schulze TG, Rietschel M, Meyer-Lindenberg A, Tost H.

J Neurosci. 2013 Apr 17;33(16):7050-6. doi: 10.1523/JNEUROSCI.3081-12.2013.

12.

Activation of midbrain and ventral striatal regions implicates salience processing during a modified beads task.

Esslinger C, Braun U, Schirmbeck F, Santos A, Meyer-Lindenberg A, Zink M, Kirsch P.

PLoS One. 2013;8(3):e58536. doi: 10.1371/journal.pone.0058536. Epub 2013 Mar 6.

13.

A novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapy.

Gupta A, Nuber N, Esslinger C, Wittenbrink M, Treder M, Landshammer A, Noguchi T, Kelly M, Gnjatic S, Ritter E, von Boehmer L, Nishikawa H, Shiku H, Old L, Ritter G, Knuth A, van den Broek M.

Cancer Immun. 2013;13:3. Epub 2013 Jan 15.

14.

Stable cognitive deficits in schizophrenia patients with comorbid obsessive-compulsive symptoms: a 12-month longitudinal study.

Schirmbeck F, Rausch F, Englisch S, Eifler S, Esslinger C, Meyer-Lindenberg A, Zink M.

Schizophr Bull. 2013 Nov;39(6):1261-71. doi: 10.1093/schbul/sbs123. Epub 2012 Oct 27.

15.

Differential effects of antipsychotic agents on obsessive-compulsive symptoms in schizophrenia: a longitudinal study.

Schirmbeck F, Rausch F, Englisch S, Eifler S, Esslinger C, Meyer-Lindenberg A, Zink M.

J Psychopharmacol. 2013 Apr;27(4):349-57. doi: 10.1177/0269881112463470. Epub 2012 Oct 24.

PMID:
23095245
16.

Memory signals from the thalamus: early thalamocortical phase synchronization entrains gamma oscillations during long-term memory retrieval.

Staudigl T, Zaehle T, Voges J, Hanslmayr S, Esslinger C, Hinrichs H, Schmitt FC, Heinze HJ, Richardson-Klavehn A.

Neuropsychologia. 2012 Dec;50(14):3519-27. doi: 10.1016/j.neuropsychologia.2012.08.023. Epub 2012 Sep 10.

PMID:
22975190
17.

Induction and quantification of prefrontal cortical network plasticity using 5 Hz rTMS and fMRI.

Esslinger C, Schüler N, Sauer C, Gass D, Mier D, Braun U, Ochs E, Schulze TG, Rietschel M, Kirsch P, Meyer-Lindenberg A.

Hum Brain Mapp. 2014 Jan;35(1):140-51. doi: 10.1002/hbm.22165. Epub 2012 Sep 11.

PMID:
22965696
18.

Ventral striatal activation during attribution of stimulus saliency and reward anticipation is correlated in unmedicated first episode schizophrenia patients.

Esslinger C, Englisch S, Inta D, Rausch F, Schirmbeck F, Mier D, Kirsch P, Meyer-Lindenberg A, Zink M.

Schizophr Res. 2012 Sep;140(1-3):114-21. doi: 10.1016/j.schres.2012.06.025. Epub 2012 Jul 10.

PMID:
22784688
19.

Neuronal correlates of social cognition in borderline personality disorder.

Mier D, Lis S, Esslinger C, Sauer C, Hagenhoff M, Ulferts J, Gallhofer B, Kirsch P.

Soc Cogn Affect Neurosci. 2013 Jun;8(5):531-7. doi: 10.1093/scan/nss028. Epub 2012 Feb 22.

20.

Test-retest reliability of evoked BOLD signals from a cognitive-emotive fMRI test battery.

Plichta MM, Schwarz AJ, Grimm O, Morgen K, Mier D, Haddad L, Gerdes AB, Sauer C, Tost H, Esslinger C, Colman P, Wilson F, Kirsch P, Meyer-Lindenberg A.

Neuroimage. 2012 Apr 15;60(3):1746-58. doi: 10.1016/j.neuroimage.2012.01.129. Epub 2012 Feb 8.

21.

Hippocampal function in healthy carriers of the CLU Alzheimer's disease risk variant.

Erk S, Meyer-Lindenberg A, Opitz von Boberfeld C, Esslinger C, Schnell K, Kirsch P, Mattheisen M, Mühleisen TW, Cichon S, Witt SH, Rietschel M, Nöthen MM, Walter H.

J Neurosci. 2011 Dec 7;31(49):18180-4. doi: 10.1523/JNEUROSCI.4960-11.2011.

22.

Test-retest reliability of resting-state connectivity network characteristics using fMRI and graph theoretical measures.

Braun U, Plichta MM, Esslinger C, Sauer C, Haddad L, Grimm O, Mier D, Mohnke S, Heinz A, Erk S, Walter H, Seiferth N, Kirsch P, Meyer-Lindenberg A.

Neuroimage. 2012 Jan 16;59(2):1404-12. doi: 10.1016/j.neuroimage.2011.08.044. Epub 2011 Aug 23.

PMID:
21888983
23.

Genetic variation in CYP2D6 impacts neural activation during cognitive tasks in humans.

Stingl JC, Esslinger C, Tost H, Bilek E, Kirsch P, Ohmle B, Viviani R, Walter H, Rietschel M, Meyer-Lindenberg A.

Neuroimage. 2012 Feb 1;59(3):2818-23. doi: 10.1016/j.neuroimage.2011.07.052. Epub 2011 Jul 30.

PMID:
21835244
24.

Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe.

Rietschel M, Mattheisen M, Degenhardt F; Genetic Risk and Outcome in Psychosis (GROUP Investigators), Mühleisen TW, Kirsch P, Esslinger C, Herms S, Demontis D, Steffens M, Strohmaier J, Haenisch B, Breuer R, Czerski PM, Giegling I, Strengman E, Schmael C, Mors O, Mortensen PB, Hougaard DM, Ørntoft T, Kapelski P, Priebe L, Basmanav FF, Forstner AJ, Hoffman P, Meier S, Nikitopoulos J, Moebus S, Alexander M, Mössner R, Wichmann H-, Schreiber S, Rivandeneira F, Hofman A, Uitterlinden AG, Wienker TF, Schumacher J, Hauser J, Maier W, Cantor RM, Erk S, Schulze TG; SGENE-plus Consortium, Craddock N, Owen MJ, O'Donovan MC, Børglum AD, Rujescu D, Walter H, Meyer-Lindenberg A, Nöthen NM, Ophoff RA, Cichon S.

Mol Psychiatry. 2012 Sep;17(9):906-17. doi: 10.1038/mp.2011.80. Epub 2011 Jul 12.

PMID:
21747397
25.

Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia.

Schirmbeck F, Esslinger C, Rausch F, Englisch S, Meyer-Lindenberg A, Zink M.

Psychol Med. 2011 Nov;41(11):2361-73. doi: 10.1017/S0033291711000419. Epub 2011 Apr 5.

PMID:
21466748
26.

Genetic risk for schizophrenia impacts Theory-of-Mind-related brain activation.

Walter H, Schnell K, Erk S, Arnold C, Kirsch P, Esslinger C, Mier D, Schmitgen MM, Rietschel M, Witt SH, Noethen MM, Cichon S, Meyer-Lindenberg A.

Mol Psychiatry. 2011 Apr;16(4):353. doi: 10.1038/mp.2011.25. No abstract available.

PMID:
21430673
27.

Cognitive state and connectivity effects of the genome-wide significant psychosis variant in ZNF804A.

Esslinger C, Kirsch P, Haddad L, Mier D, Sauer C, Erk S, Schnell K, Arnold C, Witt SH, Rietschel M, Cichon S, Walter H, Meyer-Lindenberg A.

Neuroimage. 2011 Feb 1;54(3):2514-23. doi: 10.1016/j.neuroimage.2010.10.012. Epub 2010 Oct 12.

PMID:
20946959
28.

Nicotine increases neural response to unpleasant stimuli and anxiety in non-smokers.

Kobiella A, Ulshöfer DE, Vollmert C, Vollstädt-Klein S, Bühler M, Esslinger C, Smolka MN.

Addict Biol. 2011 Apr;16(2):285-95. doi: 10.1111/j.1369-1600.2010.00237.x. Epub 2010 Aug 23.

PMID:
20731637
29.

Brain function in carriers of a genome-wide supported bipolar disorder variant.

Erk S, Meyer-Lindenberg A, Schnell K, Opitz von Boberfeld C, Esslinger C, Kirsch P, Grimm O, Arnold C, Haddad L, Witt SH, Cichon S, Nöthen MM, Rietschel M, Walter H.

Arch Gen Psychiatry. 2010 Aug;67(8):803-11. doi: 10.1001/archgenpsychiatry.2010.94.

PMID:
20679588
30.

Genome-wide association-, replication-, and neuroimaging study implicates HOMER1 in the etiology of major depression.

Rietschel M, Mattheisen M, Frank J, Treutlein J, Degenhardt F, Breuer R, Steffens M, Mier D, Esslinger C, Walter H, Kirsch P, Erk S, Schnell K, Herms S, Wichmann HE, Schreiber S, Jöckel KH, Strohmaier J, Roeske D, Haenisch B, Gross M, Hoefels S, Lucae S, Binder EB, Wienker TF, Schulze TG, Schmäl C, Zimmer A, Juraeva D, Brors B, Bettecken T, Meyer-Lindenberg A, Müller-Myhsok B, Maier W, Nöthen MM, Cichon S.

Biol Psychiatry. 2010 Sep 15;68(6):578-85. doi: 10.1016/j.biopsych.2010.05.038. Epub 2010 Jul 31.

PMID:
20673876
31.

The involvement of emotion recognition in affective theory of mind.

Mier D, Lis S, Neuthe K, Sauer C, Esslinger C, Gallhofer B, Kirsch P.

Psychophysiology. 2010 Nov;47(6):1028-39. doi: 10.1111/j.1469-8986.2010.01031.x.

PMID:
20456660
32.

The CACNA1C risk variant for bipolar disorder influences limbic activity.

Wessa M, Linke J, Witt SH, Nieratschker V, Esslinger C, Kirsch P, Grimm O, Hennerici MG, Gass A, King AV, Rietschel M.

Mol Psychiatry. 2010 Dec;15(12):1126-7. doi: 10.1038/mp.2009.103. Epub 2010 Mar 30. No abstract available.

PMID:
20351721
33.

Effects of a genome-wide supported psychosis risk variant on neural activation during a theory-of-mind task.

Walter H, Schnell K, Erk S, Arnold C, Kirsch P, Esslinger C, Mier D, Schmitgen MM, Rietschel M, Witt SH, Nöthen MM, Cichon S, Meyer-Lindenberg A.

Mol Psychiatry. 2011 Apr;16(4):462-70. doi: 10.1038/mp.2010.18. Epub 2010 Mar 16.

PMID:
20231838
34.

Neuronal correlates of affective theory of mind in schizophrenia out-patients: evidence for a baseline deficit.

Mier D, Sauer C, Lis S, Esslinger C, Wilhelm J, Gallhofer B, Kirsch P.

Psychol Med. 2010 Oct;40(10):1607-17. doi: 10.1017/S0033291709992133. Epub 2010 Jan 8.

PMID:
20056024
35.

Clozapine-induced obsessive-compulsive syndromes improve in combination with aripiprazole.

Englisch S, Esslinger C, Inta D, Weinbrenner A, Peus V, Gutschalk A, Schirmbeck F, Zink M.

Clin Neuropharmacol. 2009 Jul-Aug;32(4):227-9. doi: 10.1097/WNF.0b013e31819cc8e6.

PMID:
19644230
36.

Neural mechanisms of a genome-wide supported psychosis variant.

Esslinger C, Walter H, Kirsch P, Erk S, Schnell K, Arnold C, Haddad L, Mier D, Opitz von Boberfeld C, Raab K, Witt SH, Rietschel M, Cichon S, Meyer-Lindenberg A.

Science. 2009 May 1;324(5927):605. doi: 10.1126/science.1167768.

37.

Synthesis and preliminary pharmacological evaluation of novel derivatives of L-beta-threo-benzylaspartate as inhibitors of the neuronal glutamate transporter EAAT3.

Mavencamp TL, Rhoderick JF, Bridges RJ, Esslinger CS.

Bioorg Med Chem. 2008 Aug 15;16(16):7740-8. doi: 10.1016/j.bmc.2008.07.001. Epub 2008 Jul 8.

38.

A functional variant of the tryptophan hydroxylase 2 gene impacts working memory: a genetic imaging study.

Reuter M, Esslinger C, Montag C, Lis S, Gallhofer B, Kirsch P.

Biol Psychol. 2008 Sep;79(1):111-7. doi: 10.1016/j.biopsycho.2007.12.002. Epub 2008 Jan 30.

PMID:
18234415
39.

Influence of vigilance and learning on prefrontal activation in schizophrenia.

Esslinger C, Gruppe H, Danos P, Lis S, Broll J, Wiltink J, Gallhofer B, Kirsch P.

Neuropsychobiology. 2007;55(3-4):194-202. Epub 2007 Sep 17.

PMID:
17873494
40.
41.

Brain activation during mental maze solving.

Kirsch P, Lis S, Esslinger C, Gruppe H, Danos P, Broll J, Wiltink J, Gallhofer B.

Neuropsychobiology. 2006;54(1):51-8. Epub 2006 Sep 11.

PMID:
16966840
42.

Oxytocin modulates neural circuitry for social cognition and fear in humans.

Kirsch P, Esslinger C, Chen Q, Mier D, Lis S, Siddhanti S, Gruppe H, Mattay VS, Gallhofer B, Meyer-Lindenberg A.

J Neurosci. 2005 Dec 7;25(49):11489-93.

43.

The substituted aspartate analogue L-beta-threo-benzyl-aspartate preferentially inhibits the neuronal excitatory amino acid transporter EAAT3.

Esslinger CS, Agarwal S, Gerdes J, Wilson PA, Davis ES, Awes AN, O'Brien E, Mavencamp T, Koch HP, Poulsen DJ, Rhoderick JF, Chamberlin AR, Kavanaugh MP, Bridges RJ.

Neuropharmacology. 2005 Nov;49(6):850-61. Epub 2005 Sep 23.

PMID:
16183084
44.

The excitatory amino acid transporters: pharmacological insights on substrate and inhibitor specificity of the EAAT subtypes.

Bridges RJ, Esslinger CS.

Pharmacol Ther. 2005 Sep;107(3):271-85. Epub 2005 Apr 14. Review.

PMID:
16112332
45.

Ngamma-aryl glutamine analogues as probes of the ASCT2 neutral amino acid transporter binding site.

Esslinger CS, Cybulski KA, Rhoderick JF.

Bioorg Med Chem. 2005 Feb 15;13(4):1111-8.

PMID:
15670919
46.

In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses.

Esslinger C, Chapatte L, Finke D, Miconnet I, Guillaume P, Lévy F, MacDonald HR.

J Clin Invest. 2003 Jun;111(11):1673-81.

47.

Methylation of L-trans-2,4-pyrrolidine dicarboxylate converts the glutamate transport inhibitor from a substrate to a non-substrate inhibitor.

Esslinger C, Titus J, Koch H, Bridges R, Chamberlin A.

Bioorg Med Chem. 2002 Nov;10(11):3509-15.

PMID:
12213465
48.

Efficient transduction of dendritic cells and induction of a T-cell response by third-generation lentivectors.

Esslinger C, Romero P, MacDonald HR.

Hum Gene Ther. 2002 Jun 10;13(9):1091-100.

PMID:
12067442
49.

Synthesis and in vitro pharmacology of substituted quinoline-2,4-dicarboxylic acids as inhibitors of vesicular glutamate transport.

Carrigan CN, Bartlett RD, Esslinger CS, Cybulski KA, Tongcharoensirikul P, Bridges RJ, Thompson CM.

J Med Chem. 2002 May 23;45(11):2260-76.

PMID:
12014964
50.

Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease.

Knecht H, Berger C, McQuain C, Rothenberger S, Bachmann E, Martin J, Esslinger C, Drexler HG, Cai YC, Quesenberry PJ, Odermatt BF.

Oncogene. 1999 Nov 25;18(50):7161-7.

Supplemental Content

Loading ...
Support Center